VGINX
Price
$88.49
Change
-$0.31 (-0.35%)
Updated
Aug 15 closing price
Net Assets
6.33B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

VGINX vs VVIAX

Header iconVGINX vs VVIAX Comparison
Open Charts VGINX vs VVIAXBanner chart's image
JPMorgan US Value R6
Price$88.49
Change-$0.31 (-0.35%)
VolumeN/A
Net Assets6.33B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
VGINX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VGINX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VGINX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. VGINX (6.33B). VVIAX pays higher dividends than VGINX: VVIAX (2.18) vs VGINX (1.51). VGINX was incepted earlier than VVIAX: VGINX (10 years) vs VVIAX (25 years). VGINX (0.50) is less costly to investors than VVIAX (0.05). VGINX is a more actively managed with annual turnover of: 18.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than VGINX: VVIAX (3000) vs VGINX (15000000). VGINX (7.98) and VVIAX (7.91) have marching annual gain over last year. VGINX return over 5 years is better than : 79.04 vs. VVIAX (68.54).
VGINXVVIAXVGINX / VVIAX
Total Expense Ratio0.440.05880%
Annual Report Gross Expense Ratio0.500.051,000%
Fund Existence10 years25 years-
Gain YTD6.6936.517103%
Front LoadN/AN/A-
Min. Initial Investment150000003000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.33B196B3%
Annual Yield % from dividends1.512.1869%
Returns for 1 year7.987.91101%
Returns for 3 years29.2625.93113%
Returns for 5 years79.0468.54115%
Returns for 10 yearsN/A114.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp